Publications
-
Management of Transfusion-Dependent β-Thalassemia (TDT): Expert Insights and Practical Overview from the Middle East
β-Thalassaemia is one of the most common monogenetic diseases worldwide, with a particularly high prevalence in the Middle East region. As such, we have developed long-standing experience with disease management…
Read More » -
Challenges of Iron Chelation in Thalassemic Children
Thalassaemia treatment still relies on supportive care, mainly including blood transfusion and iron chelation therapy. Iron chelation is considered the main factor responsible for the marked improvement in survival rates…
Read More » -
Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (5th edition – 2025)
Taher, A.T. Farmakis, D. Porter, J.B. Cappellini, M.D. Musallam, K.M.
Read More » -
EU Policies Made Simple – Factsheet Series (2024)
A series of factsheets that offer an easy-to-understand overview of what Europe has achieved so far in key health policy areas, such as Access to Drugs, Cross- Border Healthcare, and…
Read More » -
TIF Literature
A Scoring System for the Assessment of Quality of Care in the Management of Transfusion-Dependent Thalassemia Angastiniotis M, Cannon L, Eleftheriou A. Hematology Reports. 2026; 18(4):46. Socio-economic disparities in clinical…
Read More » -
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about “Incidentalomas”? Results of a Long-Term Follow-Up
Abstract We retrospectively collected all ultrasound imaging data of our thalassemia patients over a period of 10 years with the aim of assessing the prevalence and the risk factors of…
Read More » -
Iron Chelation Therapy for Children with Transfusion‐Dependent β‐Thalassemia: How Young Is Too Young?
In this review, we provide a summary of evidence on iron overload in young children with transfusion-dependent β-thalassemia (TDT) and explore the ideal timing for intervention. Key data from clinical…
Read More » -
Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies
Hemoglobinopathies are monogenic disorders affecting hemoglobin synthesis. Thalassemia and sickle cell disease (SCD) are considered the two major hemoglobinopathies. Thalassemia is a genetic disorder and one of the major hemoglobinopathies…
Read More » -
Early Detection of Renal Complication in Children With Sickle Cell Disease: A Single Center Prospective Study
Introduction: This observational cross-sectional study aimed to identify predictors of renal complications in pediatric patients with sickle cell disease (SCD) at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia, over…
Read More » -
Hoping for a Normal Life: Decision‐Making on Hematopoietic Stem Cell Transplantation by Patients With a Hemoglobinopathy and Their Caregivers
Background: To provide insight into the perspectives of children and young adults with transfusion-dependent thalassemia and sickle cell disease and their caregivers regarding the decision for hematopoietic stem cell transplantation…
Read More »
